Short reportObesity is associated with retinopathy and macrovascular disease in type 1 diabetes
Introduction
People with type 1 diabetes are at increased risk of excessive body weight. Excess fat mass may have predisposed to type 1 diabetes [1], [2], [3], [4], and intensive insulin therapy to prevent vascular complications can promote weight gain [5], [6]. Several groups have found increased body mass index (BMI) or metabolic syndrome in type 1 diabetes to be associated with albuminuria, retinopathy, neuropathy and macrovascular disease [7], [8], [9]. However, studies of the relationship between body mass index (BMI) and both micro- and macrovascular outcomes of type 1 diabetes have not been described. To better define the potential impact of overweight and obesity in type 1 diabetes, we performed a cross-sectional study to determine the relationship between BMI and vascular outcomes using ‘real life’ data from a single clinical center.
Section snippets
Methods
Data was captured prospectively from treating clinicians and through linkage with Biogrid Victoria. We extracted data corresponding to the most recent clinic visit of 1223 patients with type 1 diabetes who attended between 1998 and 2011. We excluded 662 patients who did not have height data and, to avoid the potentially confounding effect of decreasing BMI in the elderly [10], another 60 patients older than 65 years.
Retinopathy was defined as prior retinal photocoagulation and/or visual acuity
Results
We identified 221 female and 280 male patients whose last clinic attendance was between 1998 and 2011 (Table 1). More than half of each gender was overweight or obese. Mean ± sd age was 30.9 ± 11.5 and 31.9 ± 11.8 years in women and men respectively. Age and disease duration increased progressively across the BMI groups, but this trend was only statistically significant for disease duration in men.
The incidence of retinopathy increased with increasing BMI in both sexes. In women, the incidence of
Conclusions
This is the first analysis of the association between obesity and both the micro- and macrovascular complications of type 1 diabetes. Consistent with prior reports [6], [8] we find a substantial rate (∼15%) of obesity in adults with type 1 diabetes. This is associated with increased risk of retinopathy and macrovascular disease that is not obviously explained by differences in glycemic control, blood pressure or use of cardioprotective drugs. These findings suggest a role for excess body mass
Conflict of interest
None of the authors declares a conflict of interest.
Author contributions
SAP collated data and prepared the manuscript, AG performed statistical analyses, SF and PGC curated the clinical database and revised the manuscript, JMW designed the study, collated data and prepared the manuscript. JMW is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
References (16)
- et al.
Undiagnosed malnutrition and nutrition-related problems in geriatric patients
J Nutr Health Aging
(2010) - et al.
Impact of obesity on cardiovascular disease
Med Clin North Am
(2011) - et al.
Reappraising the stereotypes of diabetes in the modern diabetogenic environment
Nat Rev Endocrinol
(2009) Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes
Diabetes Care
(2009)Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes
Diabetes Care
(2006)- et al.
Insulin resistance is a risk factor for progression to type 1 diabetes
Diabetologia
(2004) - The effect of intensive treatment of diabetes on the development and progression of long-term complications in...
Temporal patterns in overweight and obesity in type 1 diabetes
Diabet Med
(2010)
Cited by (54)
Clinical potential of fasting in type 1 diabetes
2024, Trends in Endocrinology and MetabolismTime-trends in body mass index, and overweight and obesity as independent risk factors for diabetes angiopathy in young females with type 1 diabetes – A nationwide study in Sweden
2023, Diabetes Research and Clinical PracticePrevalence and Clinical Determinants of Obesity in Adults With Type 1 Diabetes Mellitus: A Single-Center Retrospective Observational Study
2022, Endocrine PracticeCitation Excerpt :In a study of 326 patients between the ages of 5 and 30 years, patients with obesity had lower HDL levels and a higher prevalence of hypertension and metabolic syndrome, which is similar to our findings.23 A study including 501 patients with T1DM revealed a significantly higher incidence of macrovascular disease in patients with obesity than in nonobese patients (12% vs 4% in women and 20% vs 5% in men, P < .04 and P < .001, respectively).24 Our study found a higher prevalence of cardiovascular disease in patients with obesity (41%) than in nonobese patients (16%).
The diagnosis and management of diabetes in Australia: Does the “Rule of Halves” apply?
2020, Diabetes Research and Clinical PracticeCitation Excerpt :Davis et al. examined ethnic differences in the rate of complications, indicating Indigenous Australians had higher rates of peripheral sensory neuropathy compared with Anglo-Celts across both time periods [74]. Six studies of people with type 1 diabetes reported a lower prevalence of peripheral sensory neuropathy (18%; range 5–27%) [67,75–79]. This may have been due to three of these studies being conducted among children and adolescents and one study among young people aged from 8 to 30 years old [67,76,77,79].
A Mediterranean Diet May Be Protective in the Development of Diabetic Retinopathy
2023, International Journal of Molecular Sciences